HF Shunt Results Hold Up Midterm in Early Data
6-month follow-up with investigational device gives support for pivotal trial
Stay updated with breaking news from Alleviant System. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
6-month follow-up with investigational device gives support for pivotal trial
Hendrick Health participates in heart failure clinical study
Alleviant Medical raised $75 million to support a global pivotal trial of its catheter-delivered interatrial shunt to treat heart failure.
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Results from early clinical evaluation of the Alleviant System to treat heart failure patients with preserved and reduced ejection fraction (HFpEF and HFrEF) was presented today as late-breaking clinical research at the Society for Cardiovascular Angiography & Interventions (SCAI) 2022 Scientific Sessions.